A Study to Assess Persistence, Adherence and Changes in Disease Activity in the Children Population of Juvenile Arthritis Patients Treated With Adalimumab (HUMIRA®)
Study Identifier
P17-164
CT.gov Identifier
EudraCT Identifier
Not available
EUCTIS ID
Not available
For general inquiries, please contact
Study Complete
Results Available
Scientific Result Summary
Available Language(s): English
Study Details
Medical Condition
Study Drug
N/A
Phase
N/A
Sex
Female & Male
Age
2 - 18 Years
Protocol Summary
The objective of this study is to assess persistence, adherence and changes in disease activity in the children population of juvenile arthritis patients treated with adalimumab (HUMIRA®) in the routine clinical settings in the Russian Federation.
Study Locations
Location
Status
Location
Republican Children's Clinical Hospital /ID# 204830
Ufa, Bashkortostan Republic, Russian Federation, 450106
Status
Not applicable
Location
Chelyabinsk Regional Children's Clinical Hospital /ID# 204829
Chelyabinsk, Chelyabinsk Oblast, Russian Federation, 454087
Status
Not applicable
Location
Saratov State Medical University n.a. V.I. Razumovskiy /ID# 206319
Saratov, Saratov Oblast, Russian Federation, 410012
Status
Not applicable
Location
Kazan State Medical Academy /ID# 207004
Kazan', Russian Federation, 420012
Status
Not applicable
Location
Morozovskaya Children's City Clinical Hospital /ID# 207006
Moscow, Russian Federation, 119049
Status
Not applicable
Location
Sechenov First Moscow Medical /ID# 207005
Moscow, Russian Federation, 119992
Status
Not applicable
Showing {first} - {last} of {total} Results